Business Context and Reporting Period
This Form 6-K filing by Ambev S.A. reports on transactions of securities issued by the company involving management and related persons. The reporting period covers December 1, 2023, to December 31, 2023. The filing was signed on January 9, 2024, by Lucas Machado Lira, Chief Financial and Investor Relations Officer.
Key Financial Metrics
This filing is a regulatory disclosure of insider trading activity and does not contain consolidated financial statements. Consequently, the following metrics are not provided in this document:
- Revenue, profit, or cash flow
- Operating margins
- Debt levels or liquidity ratios
The only financial data present relates to the volume and price of specific share transactions by insiders:
- Management Restricted Share Deliveries: Total volume of approximately R$ 22.57 million across three transactions on Dec 1, Dec 3, and Dec 14.
- Management Sales: Total volume of approximately R$ 1.53 million across three sales on Dec 7, Dec 22, and Dec 27.
Material Changes
The filing details changes in shareholdings for specific groups during December 2023:
- Board of Directors: No transactions reported. Holdings remained at 10,782,599 Common Shares and 500,000 ADRs.
- Management: Significant net increase in holdings.
- Received 2,609,249 Common Shares via restricted share delivery.
- Sold 111,200 Common Shares on the open market.
- Net change: +2,498,049 Common Shares (from 2,174,739 to 3,672,788).
- Fiscal Council: No transactions reported. Holdings remained at 2,000 Common Shares.
Guidance, Outlook, and Risks
This document does not provide management commentary, financial guidance, outlook, or risk factors. It strictly complies with Article 11 of CVM Instruction # 358/2002 regarding the disclosure of securities transactions by related persons.
Investor Verification Checklist
- Verify the net increase in Management's shareholding (approx. 2.5 million shares) to assess alignment with company performance.
- Confirm the transaction prices (ranging from R$ 13.69 to R$ 14.85) against the market price of Ambev shares in December 2023.
- Note that this filing does not replace the company's quarterly or annual financial reports (Form 20-F) for operational metrics.
- Check for subsequent filings to see if the restricted shares delivered in December have vesting schedules or performance conditions.